Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Sold by Intech Investment Management LLC

Intech Investment Management LLC trimmed its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 51.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,853 shares of the real estate investment trust's stock after selling 31,589 shares during the quarter. Intech Investment Management LLC's holdings in Omega Healthcare Investors were worth $1,215,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Dimensional Fund Advisors LP grew its stake in Omega Healthcare Investors by 7.9% in the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust's stock valued at $127,831,000 after purchasing an additional 272,299 shares during the last quarter. Bank of New York Mellon Corp lifted its position in Omega Healthcare Investors by 4.6% during the second quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust's stock valued at $110,971,000 after acquiring an additional 143,521 shares during the last quarter. LSV Asset Management boosted its stake in Omega Healthcare Investors by 0.7% in the second quarter. LSV Asset Management now owns 1,968,200 shares of the real estate investment trust's stock valued at $67,411,000 after acquiring an additional 14,000 shares in the last quarter. Assetmark Inc. grew its holdings in Omega Healthcare Investors by 1.7% in the third quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust's stock worth $48,492,000 after purchasing an additional 19,542 shares during the last quarter. Finally, Daiwa Securities Group Inc. increased its position in shares of Omega Healthcare Investors by 1,030.8% during the second quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust's stock worth $32,384,000 after purchasing an additional 861,907 shares in the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, COO Daniel J. Booth sold 56,725 shares of the business's stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares of the company's stock, valued at approximately $7,357,824.44. The trade was a 10.96 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.37% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on OHI. BNP Paribas raised Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 target price on the stock in a research report on Thursday, October 31st. Wells Fargo & Company reiterated an "overweight" rating and issued a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Scotiabank upped their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a research note on Monday, August 26th. Berenberg Bank began coverage on shares of Omega Healthcare Investors in a research note on Friday, October 18th. They set a "buy" rating and a $45.00 price objective for the company. Finally, Truist Financial upped their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a research report on Wednesday, September 4th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $40.00.

Omega Healthcare Investors Stock Performance

OHI traded down $0.09 on Wednesday, reaching $40.68. The stock had a trading volume of 2,136,542 shares, compared to its average volume of 1,689,291. The business's 50-day moving average price is $40.61 and its two-hundred day moving average price is $37.19. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $44.42. The company has a market cap of $10.98 billion, a P/E ratio of 29.98, a price-to-earnings-growth ratio of 1.25 and a beta of 0.99.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were issued a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 6.59%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors's payout ratio is 197.06%.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.